Product Wiki · Recalls · U.S. FDA — Device Enforcement

IMPAX Cardiovascular (CV) Reporting Reporting tool used for… — recall Z-2184-2012

U.S. FDA — Device Enforcement · United States · 2012-07-27 · Class II

As described by U.S. FDA — Device Enforcement: IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF)

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-2184-2012
Date of alert
2012-07-27
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
AGFA Corp.
Product category
device
Product type
Devices
Recall status
Terminated — the recall action is complete and the FDA has closed it
Initiated by
Voluntary: Firm initiated
Distribution
Worldwide Distribution - USA (nationwide) and Canada
Reported risk: Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.
Primary source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?start_search=1&

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.